M A Berry

2.4k total citations
31 papers, 1.8k citations indexed

About

M A Berry is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M A Berry has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in M A Berry's work include Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). M A Berry is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). M A Berry collaborates with scholars based in United Kingdom, United States and New Zealand. M A Berry's co-authors include Ian Pavord, Andrew J. Wardlaw, Christopher E. Brightling, Dominick Shaw, Debbie Parker, Angela Morgan, Beverley Hargadon, M. Shelley, Susan McKenna and Peter Neglén and has published in prestigious journals such as New England Journal of Medicine, Scientific Reports and European Respiratory Journal.

In The Last Decade

M A Berry

28 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M A Berry United Kingdom 13 1.2k 1.1k 267 265 212 31 1.8k
Maurizio Marini Italy 20 777 0.6× 436 0.4× 177 0.7× 450 1.7× 86 0.4× 25 1.8k
Joanne Shannon Italy 16 777 0.6× 593 0.6× 330 1.2× 433 1.6× 121 0.6× 30 1.5k
Jill Adamski United States 17 187 0.2× 112 0.1× 133 0.5× 296 1.1× 84 0.4× 48 1.0k
Matthias John Germany 13 391 0.3× 497 0.5× 97 0.4× 213 0.8× 51 0.2× 23 948
Hiroaki Iijima Japan 16 382 0.3× 297 0.3× 119 0.4× 101 0.4× 59 0.3× 68 773
Eileen M. Mikat United States 24 171 0.1× 263 0.2× 681 2.6× 73 0.3× 34 0.2× 63 1.5k
Eleni Tzortzaki Greece 25 471 0.4× 881 0.8× 123 0.5× 147 0.6× 105 0.5× 58 1.4k
Eleanor Minshall Canada 16 1.3k 1.1× 694 0.7× 181 0.7× 559 2.1× 91 0.4× 28 2.0k
Shin Kurosawa Japan 19 169 0.1× 303 0.3× 261 1.0× 392 1.5× 27 0.1× 67 1.4k
Michael J. Nash United Kingdom 14 197 0.2× 92 0.1× 143 0.5× 200 0.8× 36 0.2× 38 1.3k

Countries citing papers authored by M A Berry

Since Specialization
Citations

This map shows the geographic impact of M A Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Berry more than expected).

Fields of papers citing papers by M A Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Berry. The network helps show where M A Berry may publish in the future.

Co-authorship network of co-authors of M A Berry

This figure shows the co-authorship network connecting the top 25 collaborators of M A Berry. A scholar is included among the top collaborators of M A Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Berry. M A Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, M A, et al.. (2023). Mechanisms of synergistic suppression of ALK-positive lung cancer cell growth by the combination of ALK and SHP2 inhibitors. Scientific Reports. 13(1). 10041–10041. 3 indexed citations
2.
Siva, Roshan, Christopher E. Brightling, M. Shelley, et al.. (2007). Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. European Respiratory Journal. 29(5). 906–913. 343 indexed citations
3.
Hargadon, B., Pranabashis Haldar, Dominick Shaw, et al.. (2006). Eligibility for treatment with Omalizumab among patients attending the Glenfield Hospital refractory asthma clinic. Thorax. 61. 1 indexed citations
4.
Berry, M A, Natalie Neale, Angela Morgan, et al.. (2006). Interleukin-13 expression by mast cells in the airway smooth muscle bundle in eosinophilic but not non-eosinophilic asthma. Thorax. 61.
5.
Haldar, Pranabashis, et al.. (2006). Refractory asthma phenotypes and the response to sputum eosinophil directed therapy. Thorax. 61. 1 indexed citations
6.
Berry, M A & Ian Pavord. (2006). Tumor necrosis factor alpha in refractory asthma - Reply. New England Journal of Medicine. 354. 2075–2075. 1 indexed citations
7.
Berry, M A, et al.. (2005). Clinical and pathological features of noneosinophilic asthma: A distinct asthma phenotype associated with inhaled corticosteroid resistance. Thorax. 60. 1 indexed citations
8.
Haldar, Pranabashis, et al.. (2005). Categorising the asthma phenotype: Results of a factor analysis. Thorax. 60. 1 indexed citations
9.
Berry, M A, et al.. (2005). The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clinical & Experimental Allergy. 35(9). 1175–1179. 243 indexed citations
10.
Berry, M A, Beverley Hargadon, Susan McKenna, et al.. (2005). Observational study of the natural history of eosinophilic bronchitis. Clinical & Experimental Allergy. 35(5). 598–601. 66 indexed citations
11.
Morgan, Angela, C. Guillén, Fiona A. Symon, et al.. (2005). Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clinical & Experimental Allergy. 35(12). 1572–1580. 72 indexed citations
12.
Shaw, Dominick, et al.. (2004). Reducing asthma exacerbations in practise: An observational study. Thorax. 59. 32–32. 1 indexed citations
13.
Raju, Seshadri, et al.. (2004). Venous Flow Restriction: The Role of Vein Wall Motion in Venous Admixture. European Journal of Vascular and Endovascular Surgery. 28(2). 182–192. 1 indexed citations
14.
Berry, M A, Christopher E. Brightling, Beverley Hargadon, et al.. (2003). Observational study of the natural history of eosinophilic bronchitis. Thorax. 58. 46–46. 2 indexed citations
15.
Berry, M A, Joachim Richter, B. Hargadon, et al.. (2003). Evidence of distal lung inflammation in adults with refractory asthma. Thorax. 58. 15–15. 1 indexed citations
16.
Lorber, Barbara, M A Berry, Ann Logan, & David Tonge. (2002). Effect of Lens Lesion on Neurite Outgrowth of Retinal Ganglion Cells. Molecular and Cellular Neuroscience. 21(2). 301–311. 58 indexed citations
17.
Neglén, Peter, M A Berry, & Seshadri Raju. (2000). Endovascular Surgery in the Treatment of Chronic Primary and Post-thrombotic Iliac Vein Obstruction. European Journal of Vascular and Endovascular Surgery. 20(6). 560–571. 109 indexed citations
18.
Cole, E., K.K. Foarde, M A Berry, et al.. (1994). Assessment of fungi in carpeted environments.. Cancer Treatment Reviews. 78. 103–128. 7 indexed citations
19.
Berry, M A & J A DiPalma. (1994). Review article: orthograde gut lavage for colonoscopy. Alimentary Pharmacology & Therapeutics. 8(4). 391–395. 24 indexed citations
20.
Tandon, Rakesh K., M A Berry, Yogendra Joshi, & B Pastakia. (1978). An endoscopic and roentgenologic study of oesophageal varices.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 67. 286–91. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026